Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
44 participants
OBSERVATIONAL
2023-08-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Elastography in Superficial Lymphadenopathy
NCT04561999
Different Sonographic Modalities and PET-CT in Pediatric Lymphoma
NCT05343676
Predicting Malignancy Using Endoluminal Ultrasound Characteristics in Mediastinal Lymph Nodes
NCT01329575
The Value of Ultrasound Elastography for Differentiating Benign and Malignant Superficial Soft Tissue Masses
NCT05692141
Significance of Ultrasound Elastography in Lymph Node
NCT03391557
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Lymphomas are broadly classified into Hodgkin lymphoma (HL) (10%) and Non-Hodgkin lymphoma (NHL) (90%).
HL is further classified into classical and non-classical types and NHL into B-cell, T-cell and natural killer (NK) cell types. Diagnosis of lymphoma is confirmed by histopathology (FNAC, True-cut or excisional biopsy).(2) The standard treatment of lymphoma is chemotherapy and radiotherapy.
The modalities used for staging and follow up of lymphoma are:
* Computed Tomography (CT) chest, abdomen and pelvis.
* Positron Emission Tomography (PET/CT).
* Whole body Magnetic Resonance Imaging (MRI).(3)
Sonoelastography is a new technique that depends on the elastic properties of soft tissues, with the idea of malignant lesions being stiffer than benign or normal tissue. It may have a dependable role in evaluation of therapeutic response in patients with lymphoma and can be used for follow up, the same way it has been used in different parts of the body, such as the breast, and thyroid. To the best of our knowledge, there are few studies concerning the role of elastography in the field of lymphoma disease.(4)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kerols Refaat Ayoub
Resident doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kerols Refaat, Resident
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Nagham Nabil, Professor
Role: STUDY_DIRECTOR
Assiut University
Abdel-Monem Sayed, Lecture
Role: STUDY_DIRECTOR
Assiut University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Elastography and lymphoma
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.